Position in ANNX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,863,232
+$674,829 QoQ
Shares Held
501,442
+26.9% QoQ
Ownership
0.245%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#56
of 216 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ANNX ranks #128 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,863,232 | 501,442 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,188,403 | 395,019 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,815,617 | 361,677 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $939,971 | 308,188 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $722,513 | 301,048 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $557,185 | 288,698 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,182,699 | 230,546 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,327,973 | 224,320 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,264,360 | 258,033 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,295,015 | 180,616 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $609,616 | 134,277 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $364,092 | 154,277 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $543,054 | 154,277 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $145,017 | 37,667 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $194,738 | 37,667 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $109,182 | 17,667 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $270,381 | 99,041 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,163,706 | 101,280 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,923,640 | 103,366 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,124,606 | 94,385 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,184,604 | 78,470 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,508,832 | 60,281 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,123,044 | 37,150 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||